| Preferred Name |
Fusidic Acid |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65793 |
| CAS_Registry |
6990-06-3 |
| CHEBI_ID |
CHEBI:29013 |
| Chemical_Formula |
C31H48O6 |
| code |
C65793 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A bacteriostatic antibiotic derived from the fungus Fusidium coccineum and used as a topical medication to treat skin infections. Fusidic acid acts as a bacterial protein synthesis inhibitor by preventing the turnover of elongation factor G (EF-G) from the ribosome. Fusidic acid is effective primarily on gram-positive bacteria. |
| FDA_UNII_Code |
59XE10C19C |
| label |
Fusidic Acid |
| Legacy_Concept_Name |
Fusidic_Acid |
| Preferred_Name |
Fusidic Acid |
| prefixIRI |
C65793 |
| prefLabel |
Fusidic Acid |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C0016875 |
| subClassOf |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28394 |